drugset / Trial / NCT00232362

Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes Mellitus

NCT00232362

RandomizedParallel-groupOpen-label

Summary

This study is being done to determine if pioglitazone (Actos) is helpful to patients with type 2 diabetes and could possibly prevent harmful consequences of cardiovascular disease in diabetic patients.

Timeline

Start
2007-06
Primary completion
Completion
2008-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule